WAT
47
-2
FRT
45
2
XYL
62
4
O
50
2
ECL
72
2
DHI
66
4
PDCO
46
3
AES
37
4
SHW
67
2
FSLR
47
3
KO
44
2
ZBH
45
4
RSG
70
2
ORLY
65
4
NRG
65
5
GIS
31
2
VNO
59
3
AMT
56
-3
NUE
54
3
KLAC
36
-11
WAT
47
-2
FRT
45
2
XYL
62
4
O
50
2
ECL
72
2
DHI
66
4
PDCO
46
3
AES
37
4
SHW
67
2
FSLR
47
3
KO
44
2
ZBH
45
4
RSG
70
2
ORLY
65
4
NRG
65
5
GIS
31
2
VNO
59
3
AMT
56
-3
NUE
54
3
KLAC
36
-11
Financhill
Back

PROCEPT BioRobotics Vs. Kymera Therapeutics Industry Stock Comparison

Sell
41

PRCT
PROCEPT BioRobotics

Last Price:
69.10
Seasonality Move:
4.6%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
41
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy, Sell or Hold?

  • The current PROCEPT BioRobotics [PRCT] share price is $72.46. The Score for PRCT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • PRCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PRCT Stock Price Chart

What is PROCEPT BioRobotics's stock price today?

  • The PROCEPT BioRobotics share price today is $72.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRCT is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.24 Sell
Relative Strength Index (14 RSI): 43.48 Sell
Chaikin Money Flow: -65881 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.99 - 81.45) Sell
Bollinger Bands (100): (62.11 - 77.03) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

PRCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.41 Buy
20-day SMA: 76.21 Sell
50-day SMA: 74.8 Sell
200-day SMA: 60.38 Buy
8-day EMA: 72.99 Sell
20-day EMA: 74.74 Sell
50-day EMA: 73.87 Sell
200-day EMA: 61.89 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

PROCEPT BioRobotics Earnings Growth & PRCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.43 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

PROCEPT BioRobotics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):